Does TENOFOVIR ALAFENAMIDE Cause Unevaluable event? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Unevaluable event have been filed in association with TENOFOVIR ALAFENAMIDE (VEMLIDY). This represents 0.4% of all adverse event reports for TENOFOVIR ALAFENAMIDE.
12
Reports of Unevaluable event with TENOFOVIR ALAFENAMIDE
0.4%
of all TENOFOVIR ALAFENAMIDE reports
0
Deaths
4
Hospitalizations
How Dangerous Is Unevaluable event From TENOFOVIR ALAFENAMIDE?
Of the 12 reports, 4 (33.3%) required hospitalization.
Is Unevaluable event Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TENOFOVIR ALAFENAMIDE. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does TENOFOVIR ALAFENAMIDE Cause?
Death (217)
Product dose omission issue (153)
Off label use (96)
Drug ineffective (93)
Fatigue (92)
Headache (71)
Product dose omission (69)
Intentional dose omission (67)
Product use issue (67)
Nausea (64)
What Other Drugs Cause Unevaluable event?
ADALIMUMAB (4,242)
ETANERCEPT (3,902)
LENALIDOMIDE (3,331)
OXYCODONE (3,145)
AMBRISENTAN (2,336)
SODIUM OXYBATE (2,328)
CARBIDOPA\LEVODOPA (1,632)
DUPILUMAB (1,410)
MORPHINE (1,161)
ACETAMINOPHEN\HYDROCODONE (1,118)
Which TENOFOVIR ALAFENAMIDE Alternatives Have Lower Unevaluable event Risk?
TENOFOVIR ALAFENAMIDE vs TENOFOVIR DISOPROXIL
TENOFOVIR ALAFENAMIDE vs TEPLIZUMAB-MZWV
TENOFOVIR ALAFENAMIDE vs TEPOTINIB
TENOFOVIR ALAFENAMIDE vs TEPROTUMUMAB
TENOFOVIR ALAFENAMIDE vs TEPROTUMUMAB-TRBW